ES2159021T3 - Peptidos antibioticos procedentes de leche bovina. - Google Patents
Peptidos antibioticos procedentes de leche bovina.Info
- Publication number
- ES2159021T3 ES2159021T3 ES96910013T ES96910013T ES2159021T3 ES 2159021 T3 ES2159021 T3 ES 2159021T3 ES 96910013 T ES96910013 T ES 96910013T ES 96910013 T ES96910013 T ES 96910013T ES 2159021 T3 ES2159021 T3 ES 2159021T3
- Authority
- ES
- Spain
- Prior art keywords
- amino acid
- bovine milk
- antibiotic peptides
- waste
- amino acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 241000283690 Bos taurus Species 0.000 title 1
- 230000003115 biocidal effect Effects 0.000 title 1
- 239000008267 milk Substances 0.000 title 1
- 210000004080 milk Anatomy 0.000 title 1
- 235000013336 milk Nutrition 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 150000001413 amino acids Chemical group 0.000 abstract 5
- 239000002699 waste material Substances 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
- A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
- A23B2/729—Organic compounds; Microorganisms; Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
LA INVENCION SE REFIERE A UN PEPTIDO QUE TIENE LA SECUENCIA AMINOACIDA DE FORMULA (I) H2N - X1 -R - X3 X2 - COOH, DONDE X1 ES CERO, O X1 Y/O X2 SON UN RESIDUO QUE REPRESENTA AL MENOS CINCO RESIDUOS AMINOACIDOS (SIMBOLIZADOS CON EL CODIGO DE AMINOACIDOS DE UNA LETRA), PREFERIBLEMENTE AMINOACIDOS NATURALES, CON LA CONDICION DE QUE X1 Y/O X2 CONTENGAN AL MENOS UN RESIDUO AMINOACIDO BASICO SEGUIDO INMEDIATAMENTE POR UN RESIDUO AMINOACIDO HIDROFOBO, Y X1 Y/O X2 CONTENGAN AL MENOS UN RESIDUO DE GLUTAMINA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP1996/001296 WO1997035877A1 (en) | 1996-03-25 | 1996-03-25 | Antibiotic peptides from bovine milk |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2159021T3 true ES2159021T3 (es) | 2001-09-16 |
Family
ID=8166184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES96910013T Expired - Lifetime ES2159021T3 (es) | 1996-03-25 | 1996-03-25 | Peptidos antibioticos procedentes de leche bovina. |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0889902B1 (es) |
| JP (1) | JP2000507941A (es) |
| AT (1) | ATE202363T1 (es) |
| AU (1) | AU5334296A (es) |
| DE (1) | DE69613489T2 (es) |
| ES (1) | ES2159021T3 (es) |
| WO (1) | WO1997035877A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005532784A (ja) | 2001-12-07 | 2005-11-04 | イーペーエフ ファルマシューティカルス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規の抗菌ボリシンペプチド |
| FR2901796A1 (fr) * | 2006-05-31 | 2007-12-07 | Lab Francais Du Fractionnement | Procede d'extraction d'une ou de plusieurs proteines presentes dans du lait |
| AR101099A1 (es) * | 2014-07-16 | 2016-11-23 | Dow Global Technologies Llc | Método para el tratamiento de superficies de alimentos con péptidos |
| CN104672302B (zh) * | 2014-12-18 | 2017-06-13 | 山东深海生物科技股份有限公司 | 一种多肽菌素、其制备方法及其应用 |
| CN114149486B (zh) * | 2021-05-28 | 2023-05-12 | 中国科学院大连化学物理研究所 | 一种抗菌肽mamp-01及其应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4444753C2 (de) * | 1994-12-15 | 1998-08-06 | Forssmann Wolf Georg | Antibiotisch wirksame Peptide aus der bovinen Milch, deren Gewinnung und Verwendung |
-
1996
- 1996-03-25 AU AU53342/96A patent/AU5334296A/en not_active Abandoned
- 1996-03-25 EP EP96910013A patent/EP0889902B1/en not_active Expired - Lifetime
- 1996-03-25 AT AT96910013T patent/ATE202363T1/de not_active IP Right Cessation
- 1996-03-25 ES ES96910013T patent/ES2159021T3/es not_active Expired - Lifetime
- 1996-03-25 DE DE69613489T patent/DE69613489T2/de not_active Expired - Fee Related
- 1996-03-25 JP JP09533956A patent/JP2000507941A/ja active Pending
- 1996-03-25 WO PCT/EP1996/001296 patent/WO1997035877A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE69613489D1 (de) | 2001-07-26 |
| WO1997035877A1 (en) | 1997-10-02 |
| DE69613489T2 (de) | 2002-04-25 |
| AU5334296A (en) | 1997-10-17 |
| JP2000507941A (ja) | 2000-06-27 |
| EP0889902A1 (en) | 1999-01-13 |
| EP0889902B1 (en) | 2001-06-20 |
| ATE202363T1 (de) | 2001-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE201696T1 (de) | Zyklische peptidanaloga von somatostatin | |
| AR036196A1 (es) | Agentes de contraste multimericos dirigidos a base de peptidos | |
| ES2153037T3 (es) | Lacasas purificadas de scytalidium y acidos nucleicos que las codifican. | |
| DE69434817D1 (de) | Protease varianten | |
| ES8705919A1 (es) | Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original. | |
| ES2564463T3 (es) | Péptidos antigénicos de Neisseriales | |
| DK0847278T3 (da) | Parathyroideahormon-analoger | |
| HUP9904596A1 (hu) | Mellékpajzsmirigy-hormon analógok | |
| AU1550297A (en) | Amino acid-enriched plant protein reserves, particularly lysine-enriched maize gamma-zein, and plants expressing such proteins | |
| ATE360696T1 (de) | Interferon-ähnliches protein zcyto21 | |
| DK2256205T3 (da) | Porphorymonas gingivalis-polypeptider og -polynukleotider | |
| NO971621L (no) | Keratinocyttvekstfaktoranaloger | |
| ES2159021T3 (es) | Peptidos antibioticos procedentes de leche bovina. | |
| EP0498784A3 (en) | Inhibitors of retroviral protease | |
| CO4700528A1 (es) | Peptidos de somatostatina | |
| BR9506038A (pt) | Dna clonato vetor recombinante e planta | |
| NO20012232L (no) | Enzymatisk amidering av peptider | |
| PE20000759A1 (es) | Gen de la citocroma oxidasa de hidroquinona del tipo bd | |
| ATE214731T1 (de) | Neuartige protease | |
| PT97783A (pt) | Metodo para a preparacao da enzima peptidial-hidroxiglicina n-c liase e do dna que a codifica | |
| NZ241280A (en) | Recombinant iga protease with a modified non-functional c-terminal protein sequence | |
| DE3883649D1 (de) | Therapeutische Analoga von Somatostatin. | |
| CO5090903A1 (es) | Nuevos peptidos para ser usados en una terapia de tolerancia inducida para impedir las alteraciones autoinmunes, en particular, artritis reumatoidea | |
| ES2158235T3 (es) | Peptidos antigenicos con substituciones de glicina. | |
| AR247473A1 (es) | Una composicion que produce una respuesta lactogenica o crecimiento en ganado bovino, excluidas todas sus aplicaciones terapeuticas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Grant refused |
Effective date: 19970310 |
|
| FG2A | Definitive protection |
Ref document number: 889902 Country of ref document: ES |